Beschreibung
Extra eigenschappen:
-Gluten-vrij
-Lactose-vrij
1/2 tablet per dag of zoals aanbevolen
-
Zucchetto A, Tavani A, Dal Maso L, Gallus S et Als. History of weight and obesity through life and risk of benign prostatic hyperplasia [archive], Int
J Obes (Lond), 2005;29:798-803 -
Wilt T, Ishani A, MacDonald R, Rutks I, Stark G. Pygeum africanum for benign
prostatic hyperplasia [archive], Cochrane Database Syst Rev, 1998;
(1):CD001044 -
Wilt T, Ishani A, MacDonald R. Serenoa repens for benign prostatic
hyperplasia [archive], Cochrane Database Syst Rev, 2002;(3):CD001423 -
Abe M, Ito Y, Oyunzul L, Oki-Fujino T, Yamada S. Pharmacologically relevant
receptor binding characteristics and 5alpha-reductase inhibitory activity of
free Fatty acids contained in saw palmetto extract. Biol Pharm Bull. 2009
Apr;32(4):646-50. -
DiSilverio F., D’Eramo G., et al. Evidence that Serenoa repens extract
displays an antiestrogenic activity in prostatic tissue of benign prostatic
hypertrophy patients. Eur. Urol., 21 :309-314, 1992. -
Strauch G., Perles P., et al. Comparison of finasteride and Serenoa repens
in the inhibition of 5-alpha-reductase in healthy male volunteers. Eur.
Urol., 26 :247-252, 1994. -
Thompson IM. Chemoprevention of prostate cancer: agents and study designs. J
Urol. 2007 Sep;178(3 Pt 2):S9-S13. Epub 2007 Jul 20
Niet te gebruiken bij: geen gevallen gekend.
| INGREDIENTEN PER 1/2 TABLET | ||
| Sojabonenextract (Glycine max) | 100.00 mg | |
| (40% isoflavonen) | ||
| Vit. E (D-alfatocoferolacetaat) | 25.00 mg | 208%* |
| Zink (methionine) | 21.50 mg | 215%* |
| Sabalvruchtenextract (Sabal serrulata) | 16.66 mg | |
| Gereduceerd glutathion | 7.50 mg | |
| Vit. B6 (pyridoxine HCl) | 1.50 mg | 107%* |
| Lycopeen | 0.75 mg | |
| Selenomethionine (L-selenomethionine) | 100.00 µg | 182%* |
| Hulpstoffen: dicalciumfosfaat, microkristallijne cellulose, polyvinylpyrrolidon, talk, natriumcarbyxomethylcellulose, magnesiumstearaat, siliciumdioxide *% RI = Referentie Inname (E.C.) |
||
